<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="as a supplementary drug in the management of type 2" exact="diabetes mellitus" post="(T2DM) due to their reported pronounced biological effects in"/>
 <result pre="and slow down the progression of long-term diabetes complications including" exact="cardiovascular disease," post="nephropathy, neuropathy, and retinopathy. Further thoroughgoing investigations in human"/>
 <result pre="patients. isoflavonoids biochanin A genistein daidzein glycitein formononetin type 2" exact="diabetes mellitus" post="diabetes complications mechanism of action 1. Introduction Diabetes mellitus"/>
 <result pre="mechanism of action 1. Introduction Diabetes mellitus (DM) is a" exact="metabolic disorder" post="related to reduced sensitivity of tissue receptors toward insulin,"/>
 <result pre="does not function properly (Type 2 diabetes mellitus), resulting in" exact="hyperglycemia" post="[1]. Due to uncontrolled blood sugar, this pathogenic condition"/>
 <result pre="complications like micro- and macrovascular complications. Microvascular complications generally include" exact="neuropathy" post="(nerve damage), nephropathy (renal disease), and retinopathy (vision disorders)"/>
 <result pre="and macrovascular complications. Microvascular complications generally include neuropathy (nerve damage)," exact="nephropathy" post="(renal disease), and retinopathy (vision disorders) while macrovascular complications"/>
 <result pre="complications generally include neuropathy (nerve damage), nephropathy (renal disease), and" exact="retinopathy" post="(vision disorders) while macrovascular complications are coronary artery disease,"/>
 <result pre="life and increase the risk of mortality [2,3]. Type 2" exact="diabetes mellitus" post="is the most prevalent, which consolidates above 90% of"/>
 <result pre="of cost and time effective measures be taken immediately against" exact="diabetes mellitus" post="treatment to reduce the high morbidity and mortality rate"/>
 <result pre="[6]. There are many drugs available in the management of" exact="diabetes mellitus" post="including insulin, Î±-glucosidase inhibitors (acarbose, miglitol, voglibose), amylin analogs"/>
 <result pre="sorbitol has been reported to cause chronic impediments such as" exact="peripheral neuropathy," post="retinopathy, and cataracts. Additionally, aldose reductase has been found"/>
 <result pre="been claimed to be associated with the development of diabetic" exact="nephropathy" post="[9]. Hence, aldose reductase inhibitors can be seen as"/>
 <result pre="potential avenue in the development of new pharmacological therapy in" exact="diabetes mellitus." post="Similarly, there has been a growing interest in antidiabetic"/>
 <result pre="further supports the association of isoflavonoids with anticancer effects against" exact="breast cancer" post="and post-menopausal abnormality [30]. Jang et al. [23] mentioned"/>
 <result pre="supports the association of isoflavonoids with anticancer effects against breast" exact="cancer" post="and post-menopausal abnormality [30]. Jang et al. [23] mentioned"/>
 <result pre="risk reduction of chronic diseases including cardiovascular diseases, diabetes, cancer," exact="osteoporosis" post="and obesity [25] as well as diminished menopausal symptoms"/>
 <result pre="of chronic diseases including cardiovascular diseases, diabetes, cancer, osteoporosis and" exact="obesity" post="[25] as well as diminished menopausal symptoms [26,27]. 2."/>
 <result pre="explore the potential role of isoflavonoids in the treatment of" exact="diabetes mellitus." post="Results from in vitro and in vivo studies have"/>
 <result pre="to enrich the recent therapy options against the manifestation of" exact="diabetes mellitus" post="[43,44]. 2.2.1. Peroxisome Proliferator-Activated Receptors Î± and Î³ Isoflavonoids"/>
 <result pre="(PPARs), which play an important role in gene expression in" exact="diabetes mellitus" post="[45]. Moreover, PPARs have been found to be highly"/>
 <result pre="that agonists of PPARÎ³ could be therapeutically considered to counter" exact="hyperglycemia" post="elicited due to type 2 diabetes. An oral antidiabetic"/>
 <result pre="target PPARÎ± and PPARÎ³ could potentially be used to regulate" exact="dyslipidemia" post="and restore glycemic balance, respectively. Due to the fact"/>
 <result pre="that red clover extract containing biochanin A and formononetin ameliorated" exact="dyslipidemia" post="in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARÎ±"/>
 <result pre="levels of serum triglyceride, and also alleviated insulin resistance and" exact="glucose intolerance" post="in db/db obese mice. These effects were the result"/>
 <result pre="Î²-Cell Function It has been confirmed that abnormal digestion and" exact="malabsorption" post="of dietary carbohydrate are mainly responsible for reduced glycogen"/>
 <result pre="insulin signaling pathways, which greatly contribute to the manifestation of" exact="diabetes mellitus" post="[59]. The hypoglycemic effect of isoflavonoids has also been"/>
 <result pre="be able to regulate postprandial glycemia and inhibit development of" exact="glucose intolerance" post="by facilitating insulin response as well as inducing insulin"/>
 <result pre="It is known that peripheral insulin resistance is common during" exact="obesity" post="and aging in mice and people. The progression to"/>
 <result pre="insulin-mediated GLUT4 translocation in adipocytes. Mac-CM, an inflammatory stimulus, induced" exact="glucose intolerance" post="accompanied by impaired insulin sensitivity; genistein reversed these changes"/>
 <result pre="hypoglycemic action, which could be useful in the treatment of" exact="diabetes mellitus." post="Rauter et al. [97] also evaluated the antidiabetic effect"/>
 <result pre="diabetic rats. It was found to produce normalization of fasting" exact="hyperglycemia" post="and amelioration of excessive postprandial glucose excursions and increasing"/>
 <result pre="have potential for development into novel treatment strategies for chronic" exact="obesity" post="and diabetes. Choi et al. [95] reported that the"/>
 <result pre="of genistein and daidzein are seemingly helpful for preventing insulin-dependent" exact="diabetes mellitus" post="(IDDM) onset. Apart from the above, daidzein has also"/>
 <result pre="serum insulin and insulin resistance in an animal model of" exact="obesity" post="and diabetes [107]. Ae Park et al. [102] reported"/>
 <result pre="that biochanin A demonstrated inhibitory activity on protein glycosylation in" exact="diabetic retinopathy." post="Vedavanam et al. [65] demonstrated that genistein containing soybean"/>
 <result pre="a hypoglycemic effect on a rat experimental model of postmenopausal" exact="metabolic syndrome" post="[112]. Genistein also modified liver function and mitigated non-alcoholic"/>
 <result pre="syndrome [112]. Genistein also modified liver function and mitigated non-alcoholic" exact="fatty liver disease" post="in a rat model of insulin resistance [113]. Interestingly,"/>
 <result pre="[112]. Genistein also modified liver function and mitigated non-alcoholic fatty" exact="liver disease" post="in a rat model of insulin resistance [113]. Interestingly,"/>
 <result pre="bring specific antidiabetic activity toward a specific mechanism in treating" exact="diabetes mellitus." post="Furthermore, further investigations in human clinical studies are highly"/>
 <result pre="isoflavone intake among middle-aged Chinese menJ. Nutr.20071371011101610.1093/jn/137.4.101117374669 19.Horn-RossP.L.JohnE.M.CancholaA.J.StewartS.L.LeeM.M.Phytoestrogen intake and" exact="endometrial cancer" post="riskJ. Natl. Cancer Inst.2003951158116410.1093/jnci/djg01512902445 20.ChunO.K.ChungS.J.SongW.O.Estimated dietary flavonoid intake and"/>
 <result pre="intake among middle-aged Chinese menJ. Nutr.20071371011101610.1093/jn/137.4.101117374669 19.Horn-RossP.L.JohnE.M.CancholaA.J.StewartS.L.LeeM.M.Phytoestrogen intake and endometrial" exact="cancer" post="riskJ. Natl. Cancer Inst.2003951158116410.1093/jnci/djg01512902445 20.ChunO.K.ChungS.J.SongW.O.Estimated dietary flavonoid intake and"/>
 <result pre="SoyfoodFood Sci. Biotechnol.200615643646 24.IwasakiM.InoueM.OtaniT.SasazukiS.KurashiN.MiuraT.YamotoS.TsuganeS.Plasma isoflavone level and subsequent risk of" exact="breast cancer" post="among Japanese women: A nested case-control study from Japan"/>
 <result pre="Sci. Biotechnol.200615643646 24.IwasakiM.InoueM.OtaniT.SasazukiS.KurashiN.MiuraT.YamotoS.TsuganeS.Plasma isoflavone level and subsequent risk of breast" exact="cancer" post="among Japanese women: A nested case-control study from Japan"/>
 <result pre="and genistein may be related to ERÎ±/c-erbB-2 expression in human" exact="breast cancer" post="cellsMol. Med. Rep.2013778178410.3892/mmr.2013.128323337939 29.MolteniA.Brizio-MolteniL.PerskyV.In vitro hormonal effects of soybean"/>
 <result pre="genistein may be related to ERÎ±/c-erbB-2 expression in human breast" exact="cancer" post="cellsMol. Med. Rep.2013778178410.3892/mmr.2013.128323337939 29.MolteniA.Brizio-MolteniL.PerskyV.In vitro hormonal effects of soybean"/>
 <result pre="lipid metabolism in rats fed cholesterolJ. Nutr. Biochem.20051620521210.1016/j.jnutbio.2004.11.00515808324 32.YangW.WangS.LiL.LiangZ.WangL.Genistein reduces" exact="hyperglycemia" post="and islet cell loss in a high-dosage manner in"/>
 <result pre="polyphenols on intestinal absorption of glucose and fructose: Relation with" exact="obesity" post="and type 2 diabetesJ. Food Rev. Int.20193539040610.1080/87559129.2019.1573432 44.SunL.MiaoM.Dietary polyphenols"/>
 <result pre="and murine RAW 264.7 cellsJ. Nutr.20031331238124310.1093/jn/133.5.123812730403 52.QiuL.YeH.ChenL.HongY.ZhongF.ZhangT.Red clover extract ameliorates" exact="dyslipidemia" post="in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARÎ±Phytother."/>
 <result pre="PPARÎ±Phytother. Res.20122686086410.1002/ptr.364122084061 53.HooR.L.WongJ.Y.QiaoC.XuA.XuH.LamK.S.The effective fraction isolated from Radix astragali alleviates" exact="glucose intolerance," post="insulin resistance and hypertriglyceridemia in db/db diabetic mice through"/>
 <result pre="db/db diabetic mice through its anti-inflammatory activityNutr. Metab.201076710.1186/1743-7075-7-6720735814 54.SongM.K.RoufogalisB.D.HuangT.H.W.Modulation of" exact="diabetic retinopathy" post="pathophysiology by natural medicines through PPAR-Î³-related pharmacologyBr. J. Pharm.201216541910.1111/j.1476-5381.2011.01411.x21480863"/>
 <result pre="diabetic mice through its anti-inflammatory activityNutr. Metab.201076710.1186/1743-7075-7-6720735814 54.SongM.K.RoufogalisB.D.HuangT.H.W.Modulation of diabetic" exact="retinopathy" post="pathophysiology by natural medicines through PPAR-Î³-related pharmacologyBr. J. Pharm.201216541910.1111/j.1476-5381.2011.01411.x21480863"/>
 <result pre="between Î²-cell mass and diabetes onsetDiabetes Obes. Metab.200810233110.1111/j.1463-1326.2008.00939.x18834430 93.FuZ.GilbertE.R.PfeifferL.ZhangY.FuY.LiuD.Genistein ameliorates" exact="hyperglycemia" post="in a mouse model of nongenetic type 2 diabetesAppl."/>
 <result pre="105.ParkM.H.JuJ.W.ParkM.J.HanJ.S.Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial" exact="hyperglycemia" post="in diabetic miceEur. J. Pharm.2013712485210.1016/j.ejphar.2013.04.047 106.SeoS.G.YangH.ShinS.H.MinS.KimY.A.YuJ.G.LeeD.E.ChungM.HeoY.KwonJ.Y.et al.A metabolite of"/>
 <result pre="PI3K. MolNutr. Food Res.2013571446145510.1002/mnfr.201200593 107.BhathenaS.J.VelasquezM.T.Beneficial role of dietary phytoestrogens in" exact="obesity" post="and diabetesAm. J. Clin. Nutr.2002761191120110.1093/ajcn/76.6.119112450882 108.ZangY.IgarashiK.YuC.Anti-obese and anti-diabetic effects"/>
 <result pre="metabolic syndromeJ. Endocrinol.200920036737610.1677/JOE-08-020619066292 113.SalihM.NallasamyP.MuniyandiP.PeriyasamiV.VenkatramanA.C.Genistein improves liver function and attenuates non-alcoholic" exact="fatty liver disease" post="in a rat model of insulin resistanceJ. Diabetes.2009127828710.1111/j.1753-0407.2009.00045.x20923528 114.LeeJ.S.Effects"/>
 <result pre="syndromeJ. Endocrinol.200920036737610.1677/JOE-08-020619066292 113.SalihM.NallasamyP.MuniyandiP.PeriyasamiV.VenkatramanA.C.Genistein improves liver function and attenuates non-alcoholic fatty" exact="liver disease" post="in a rat model of insulin resistanceJ. Diabetes.2009127828710.1111/j.1753-0407.2009.00045.x20923528 114.LeeJ.S.Effects"/>
</results>
